Abstract：Objective: To investigate the expression and clinical significance of CD68-labeled tumor-associated macrophages (CD68-TAMS) and CD105-labeled microvascular density (CD105-MVD) in laryngeal squamous cell carcinoma. Methods: The paraffin specimens of 40 cases of laryngeal squamous cell carcinoma confirmed by surgical resection and pathological examination were retrospectively studied, and 20 cases of adjacent normal tissues (not infiltrated by laryngeal carcinoma cells) were used as control group. Immunohistochemical SP method was used to detect the protein expression of CD68-Tams and CD105 and microvessel density MVD. Kaplan-meier method was used to analyze the relationship between the expression of CD68-Tams and CD105-MVD and the prognosis of patients. Results: The positive expression rate of CD68-TAMS in laryngeal cancer group (77.5%, 31/40) was significantly higher than that in control group (20.00%, 2/20), and the difference was statistically significant (P<0.05). The positive expression rate of CD105-MVD in laryngeal carcinoma group (72.50%, 31/40) was significantly higher than that in control group (30.0%, 6/20) (P<0.05). The expression of CD68-Tams was correlated with lymph node metastasis, tumor differentiation and TNM stage (P<0.05), and the expression of CD105-MVD was correlated with lymph node metastasis and tumor differentiation (P<0.05). The 3-year survival rate of patients with positive CD68-Tams expression was lower than that of patients with low CD68-TAMS expression (P<0.05). The 3-year survival rate of patients with positive CD105-MVD expression was lower than that of patients with low CD105-MVD expression (P<0.05). Cox regression analysis showed that positive CD68-TAMs, positive CD105-MVD, tumor stage and lymph node metastasis were independent influencing factors for poor prognosis of laryngeal cancer (P<0.05). Conclusion: The expression of CD68-TAMs and CD105-MVD in laryngeal cancer tissues indicates that they promote tumor angiogenesis and tumor development, and can be used as markers for the diagnosis of laryngeal squamous cell carcinoma. Positive CD68-TAMs, positive CD105-MVD, tumor staging and lymph node metastasis in laryngeal cancer tissues are closely related to prognosis.It can be used as an independent evaluation indicator of poor prognosis of laryngeal cancer.
[1] 范义燕,张肖林,刘秀珍,等.CPS1在喉鳞癌组织中的表达及临床意义[J].山东大学耳鼻喉眼学报,2020,34(6):72-76. [2] Xu L,Shen M,Chen X,et al.Corrigendum to “In vitro-induced M2 type macrophages induces the resistance of prostate cancer cells to cytotoxic action of NK cells”[J].Experimental Cell Research,2020,391(1):112006. [3] Cai J,Qiao B,Gao N,et al.Oral squamous cell carcinoma-derived exosomes promote M2 subtype macrophage polarization mediated by exosome-enclosed miR-29a-3p[J].American Journal of Physiology-Cell Physiology,2019,316(5):731-740. [4] Marioni G,Franz L,Ottaviano G,et al.Prognostic significance of CD105- and CD31-assessed microvessel density in paired biopsies and surgical samples of laryngeal carcinoma[J].Cancers,2020,12(8):2059. [5] Sawaki M,Shien T,Iwata H.TNM classification of malignant tumors (breast cancer study group)[J].Japanese Journal of Clinical Oncology,2019,49(3):228-231. [6] 王维伊,钟山亮,闫林萍,等.巨噬细胞集落刺激因子对巨噬细胞极化及卵巢癌细胞侵袭、转移的影响[J].临床检验杂志,2019,37(7):512-517. [7] Su C,Fu X,Duan W,et al.High density of CD68+ tumor-associated macrophages predicts a poor prognosis in gastric cancer mediated by IL-6 expression[J].Oncology letters,2018,15(5):6217-6224. [8] Yang Y,Zhou Y,Hou J,et al.Hepatic IFIT3 predicts interferon-alpha therapeutic response in patients of hepatocellular carcinoma[J].Hepatology,2017,66(1):152-166. [9] Zhou L,Li Y,Gao W,et al.Assessment of tumor-associated immune cells in laryngeal squamous cell carcinoma[J].Journal of Cancer Research and Clinical Oncology,2019,145(7):1761-1772. [10] Marioni G,Franz L,Ottaviano G,et al.Prognostic significance of CD105- and CD31-assessed microvessel density in paired biopsies and surgical samples of laryngeal carcinoma[J].Cancers,2020,12(8):2059.
2023, Vol. 29 
冀公网安备13080202000677号